Loading…
Based on limited metadata, this FDA Warning Letter issued to Wizman Limited on April 27, 2020, concerns tobacco products. Without access to the full letter text or subject line, the specific nature of the violations cannot be determined from the available information. The warning falls under FDA tobacco product regulation, though the specific issuing office is not documented in the metadata provided. Additional details regarding the company's compliance failures would require review of the complete Warning Letter.